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chest angina. He had exertion
chest discomfort 1 month ago. He
had no cardiovascular risk factors.
Chest X-ray revealed no cardio-
megaly. Electrocardiogram revealed
ST-segment elevation in lead II, III,
and aVF. Echocardiography showed
hypokinesia in inferior wall with an
ejection fraction of 45%. We diag-
nosed ST-elevation myocardial infarc-
tion in inferior wall. We performed a
coronary angiography (CAG) for
primarypercutaneouscoronaryinter-
vention. The CAG showed a signiﬁ-
cant stenosis with plaque rupture at
bifurcation portion of postero-lateral
branch and postero-descending
branch of the right coronary artery
(RCA), which is considered as
infarct-related artery, and a signiﬁcant
stenosisatproximalportionoftheleft
anteriordescendingartery(LAD)and
the left circumﬂex artery (LCX).
The RCA lesion was pre-dilated
and implanted (zotarolimus-eluting
stent 3.5   24 mm). After 3 days,
we implanted two different stents
at two signiﬁcant lesions of LAD
and LCX (LAD: sirolimus-eluting stent 3.5   23 mm; LCX: paclitaxel-eluting stent 3.5   24 mm) because of product delivery
(Panels A, B, and C). We treated with aspirin 100 mg/day and clopidogrel 75 mg/day.
Six months later, he was admitted at our hospital due to atypical chest pain. We performed CAG. Follow-up CAG revealed huge
aneurysms around the stents in RCA and LCX and small aneurysm around the stent in LAD (Panels D, E, and F). The aneurysms were
clearly visible on intravascular ultrasound (Panels G, H, and I). We decided to treat with medication of three anti-platelet agents
(aspirin, clopidogrel, and cilostazol) without additional intervention. He has been free of symptom until now.
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